These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7716951)

  • 1. [Evaluation of arrhythmia in patients with acute myocardial infarction receiving neoton (phosphocreatine)].
    Tomaszewski A; Markiewicz M; Dabrowski P; Baszak J; Jach A; Trojnar R; Wysokiński A
    Wiad Lek; 1994 Aug; 47(15-16):570-3. PubMed ID: 7716951
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neoton and thrombolytic therapy of myocardial infarction].
    Perepech NB; Nedoshivin AO; Nesterova IV
    Ter Arkh; 2001; 73(9):50-5. PubMed ID: 11642083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prophylactic use of Neoton in cardiac failure in patients with myocardial infarction].
    Perepech NB; Nedoshivin AO; Kutuzova A'E
    Klin Med (Mosk); 1997; 75(10):52-4. PubMed ID: 9490342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Exogenous phosphocreatine in the prevention and treatment of cardiac insufficiency in patients with myocardial infarction].
    Perepech NB; Nedoshivin AO; Kutuzova AE
    Klin Med (Mosk); 1993 Jan; 71(1):19-22. PubMed ID: 8046897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of creatine phosphate (Neoton) in acute myocardial infarct (a prospective multicenter pilot study].
    Stejfa M; Zeman K; Groch L; Marek J; Komárek J; Janota T; Vávra F; Kölbel F; Charvát I; Weinbergová O
    Vnitr Lek; 1993 Feb; 39(2):136-42. PubMed ID: 8506660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metoprolol in acute myocardial infarction--clinical effect and tolerance].
    Dłuzniewski M; Jurgiel R; Budaj A
    Kardiol Pol; 1985; 28(11):683-9. PubMed ID: 3915041
    [No Abstract]   [Full Text] [Related]  

  • 7. Dynamics of some biochemical indices in myocardial infarction treated with thrombolysis and creatine phosphate.
    Weinbergová O; Zeman K; Komárek J; Kölbel F; Metelka R; Ostranský J
    Acta Univ Palacki Olomuc Fac Med; 1996; 140():91-4. PubMed ID: 9431703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Creatine phosphate as a drug in acute myocardial infarct].
    Komárek J; Strnadová V
    Cas Lek Cesk; 1992 Apr; 131(8):248-9. PubMed ID: 1638616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lidocaine as an anti-arrhythmia agent. Experiences with 68 patients].
    Flensted-Jensen E; Sandoe E
    Ugeskr Laeger; 1969 Mar; 131(12):504-7. PubMed ID: 5793605
    [No Abstract]   [Full Text] [Related]  

  • 10. [On complicated rhythm disorders in patients with myocardial infarct arising under the influence of strophanthin].
    Ostapiuk FE
    Ter Arkh; 1967 May; 39(5):105-7. PubMed ID: 5610166
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adrenergic beta-receptor blockage in the treatment of acute myocardial infarction].
    Raeder S; Bjark P
    Nord Med; 1967 Aug; 78(34):1091-3. PubMed ID: 6033068
    [No Abstract]   [Full Text] [Related]  

  • 12. [The influence of induced severe myocardial ischemia on coronary disease course].
    Poniatovskiĭ IM; Zelenin AV; Emel'ianov SV; Nikolaeva EIu; Tepaeva IA
    Voen Med Zh; 2005 Oct; 326(10):16-21, 80. PubMed ID: 16353868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of atropine on the heart].
    Naess K
    Tidsskr Nor Laegeforen; 1975 May; 95(14):900-1. PubMed ID: 1135831
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of diabetes mellitus and its treatment on ventricular arrhythmias complicating acute myocardial infarction.
    Rana JS; Mukamal KJ; Nesto RW; Morgan JP; Muller JE; Mittleman MA
    Diabet Med; 2005 May; 22(5):576-82. PubMed ID: 15842512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enalapril reduces the degree of left ventricular remodeling after acute myocardial infarction and reduces the incidence of arrhythmia in ischemic disease].
    Altieri PI; González R; de Mello W; Escobales N
    Rev Port Cardiol; 1994 Dec; 13(12):913-7, 892. PubMed ID: 7873221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reperfusion arrhythmias in acute myocardial infarction.
    Gao RL; Yao KB; Chen JL; Yang YJ; Xu YS; Chen ZJ
    Chin Med J (Engl); 1993 Jul; 106(7):514-7. PubMed ID: 8243123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of propafenone in the treatment of ventricular arrhythmias with a malignant potential for resistance to conventional anti-arrhythmia medication].
    Câmpeanu A; Rădoi M; Serban-Pârâu G; Pleşca O; Nuţă M; Teodorescu V; Titirigă M
    Med Interna; 1993; 45(1-2):35-41. PubMed ID: 8081689
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of primary ventricular fibrillation in acute myocardial infarction with prophylactic lidocaine.
    Wyman MG; Wyman RM; Cannom DS; Criley JM
    Am J Cardiol; 2004 Sep; 94(5):545-51. PubMed ID: 15342281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta-blocker therapy in the management of malignant ventricular arrhythmia in patients with acute myocardial infarction].
    Ma HL; Fang YM; Ma YL; Feng J; Wang KQ; Ge JB
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Apr; 24(4):475-6. PubMed ID: 15090331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of 24 h, nonfatal complications in patients with acute myocardial infarction receiving thrombolytic therapy by calculation of the ST segment deviation score.
    Schreiber W; Kittler H; Pieper O; Woisetschlaeger C; Laggner AN; Hirschl MM
    Can J Cardiol; 2003 Feb; 19(2):151-7. PubMed ID: 12601440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.